Turaver 10
4-Chlorodehydromethyltestosterone 10mg tablets (oral Turinabol). Clean anabolic gains without estrogenic activity or aromatization.
Turaver 10
Turaver 10 is a pharmaceutical tablet formulation of 4-Chlorodehydromethyltestosterone — universally known as oral Turinabol or Tbol — at 10 milligrams per tablet. Developed in East Germany in the early 1960s, oral Turinabol is pharmacologically characterized by clean anabolic gains, the complete absence of estrogenic activity, and a relatively mild androgenic profile compared to testosterone.
Structural Profile
4-Chlorodehydromethyltestosterone incorporates three structural modifications to testosterone: a 4-chloro substitution, a 1,2-double bond (delta-1 dehydrogenation), and a 17-alpha methyl group. The 4-chloro substitution at C-4 completely prevents aromatization — the compound cannot be converted to any estrogen under any conditions. The delta-1 modification reduces androgenic potency relative to testosterone, while the 17-alpha methyl group confers oral bioavailability. The net result is a compound with an anabolic-to-androgenic ratio of approximately 100:6 (vs testosterone 100:100) — high anabolic selectivity with minimal androgenic burden.
Pharmacokinetic Profile
Oral Turinabol is absorbed from the gastrointestinal tract with moderate bioavailability. Peak plasma concentrations are achieved within 3–4 hours post-dose. The elimination half-life is approximately 16 hours, making once-daily dosing pharmacokinetically feasible. Critically, epimeric metabolites and long-chain fatty acid ester conjugates are detectable in urine for up to 11–12 months after last administration using modern high-resolution mass spectrometry — producing one of the longest detection windows of any oral anabolic compound.
Mechanism of Action
Free 4-Chlorodehydromethyltestosterone binds the androgen receptor with moderate affinity, initiating androgen-responsive gene transcription governing protein synthesis and nitrogen retention in skeletal muscle. The absence of aromatization means there is no estrogenic water retention, producing lean, dry muscular development. The compound also exhibits moderate SHBG-displacing activity, increasing the free fraction of co-administered androgens.
Formulation
Each Turaver 10 tablet contains 10 mg 4-Chlorodehydromethyltestosterone USP as active ingredient. Manufactured to USP specification under GMP-compliant conditions with pharmaceutical-grade excipients. Complete release testing — HPLC concentration (95–105% label claim), purity (≥98%), dissolution, microbiological limits — is performed on every production batch prior to distribution.
Quality Assurance
Every batch of Turaver 10 produced by Biomedica undergoes the complete pharmaceutical release testing protocol before distribution. This includes HPLC compound identity confirmation and purity analysis (specification: ≥98%), concentration verification (specification: ±5% of label claim), sterility testing per USP <71>, bacterial endotoxin quantification by LAL assay (specification: <0.25 EU/mL), and particulate matter inspection per USP <788>. A Certificate of Analysis is issued for every production lot.
Authentication
Each unit of Turaver 10 carries a unique authentication code on its outer packaging. This code can be verified instantly on our Authentication page to confirm the product is genuine Biomedica stock.